Why this matters: BIRK jumped 11.6% Thursday. Short sellers are covering. But the lending market is frozen — leaving bears with nowhere to go and puts piling up at a 52-week record.
Short interest has fallen sharply. It dropped 11.1% over the past week to 4.5% of float. Over 30 days, it's down 30.3%. Bears have been cutting exposure steadily since early July, when shares short topped 12 million.
The exits aren't coming easily. Availability has collapsed to just 0.44% — meaning for every 200 shares already borrowed, fewer than one remains in the lending pool. That's essentially zero. The lending market has run at this extreme for 52 consecutive days. Cost to borrow is 13.3%, down from July peaks near 25% but still classified as elevated.
The scarcity is self-reinforcing. As shorts try to unwind, they return shares — but so few new borrows are available that any replacement positioning is nearly impossible. Bears who exit cannot easily re-enter.
Here's the tension: as the stock rallied sharply Thursday, the put-call ratio hit 4.88 — its highest level in 52 weeks. That's 3.4 standard deviations above the 20-day mean of 2.81.
The previous sessions showed a PCR sitting calmly in the 2.4–2.9 range. Yesterday's session broke that range violently to the upside. That level of put activity on a day the stock surges 11.6% is an unusual divergence. Options traders were positioning defensively — or outright bearishly — even as the price ripped higher.
The 52-week PCR range runs from 0.44 to 4.88. Thursday's print is the high end of everything seen in the past year.
Earnings landed yesterday. BTIG reiterated its Buy today with a $60 target. JP Morgan raised its target to $58 from $49 earlier this month. UBS trimmed slightly to $76. Raymond James initiated at $52 Outperform in July.
The mean analyst target sits at $47.16. The stock closed Wednesday at $41. That's 15% implied upside to consensus — but the distribution of targets ($45–$76) suggests wide disagreement on the recovery path.
The ORTEX short score sits at 76.8, ranked in the 2nd percentile of all stocks — one of the most shorted profiles in the market by this measure, even as the raw share count declines.
See the live data behind this article on ORTEX.
Open BIRK on ORTEX →ORTEX Market Intelligence content is generated by AI from a snapshot of ORTEX's proprietary data. Content is informational only and does not constitute investment advice.
